{"total_count":10006019,"current_page":378702,"per_page":20,"docs":[{"id":10276551,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"HMST_TIERONERISKBASEDCAPITALREQUIREDTOBEWELLCAPITALIZEDTORISKWEIGHTEDASSETS_Q","name":"HomeStreet, Inc.  (HMST): Quarterly Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets","urlize_name":"HomeStreet-Inc-HMST-Quarterly-Tier-One-Risk-Based-Capital-Required-To-Be-Well-Capitalized-To-Risk-Weighted-Assets","description":"SEC Name: TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets","updated_at":"2014-03-06T20:00:42Z","frequency":"annual","from_date":"2011-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276552,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"HMST_TIERONERISKBASEDCAPITALREQUIREDTOBEWELLCAPITALIZED_A","name":"HomeStreet, Inc.  (HMST): Annual Tier One Risk Based Capital Required To Be Well Capitalized","urlize_name":"HomeStreet-Inc-HMST-Annual-Tier-One-Risk-Based-Capital-Required-To-Be-Well-Capitalized","description":"SEC Name: TierOneRiskBasedCapitalRequiredToBeWellCapitalized","updated_at":"2014-03-06T20:00:59Z","frequency":"annual","from_date":"2011-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10272069,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"NEO_COMMONSTOCKVALUE_Q","name":"NEOGENOMICS INC  (NEO): Quarterly Common Stock Value","urlize_name":"NEOGENOMICS-INC-NEO-Quarterly-Common-Stock-Value","description":"SEC Name: CommonStockValue","updated_at":"2014-03-06T20:00:59Z","frequency":"annual","from_date":"2010-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10271950,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"NEO_COMMONSTOCKSHARESOUTSTANDING_Q","name":"NEOGENOMICS INC  (NEO): Quarterly Common Stock Shares Outstanding","urlize_name":"NEOGENOMICS-INC-NEO-Quarterly-Common-Stock-Shares-Outstanding","description":"SEC Name: CommonStockSharesOutstanding","updated_at":"2014-03-06T20:00:42Z","frequency":"annual","from_date":"2010-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273326,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"NEO_COSTOFSERVICES_Q","name":"NEOGENOMICS INC  (NEO): Quarterly Cost Of Services","urlize_name":"NEOGENOMICS-INC-NEO-Quarterly-Cost-Of-Services","description":"SEC Name: CostOfServices","updated_at":"2014-03-06T20:00:42Z","frequency":"daily","from_date":"2011-06-30","to_date":"2013-09-30","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276353,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"NEO_DEPOSITSASSETSNONCURRENT_Q","name":"NEOGENOMICS INC  (NEO): Quarterly Deposits Assets Noncurrent","urlize_name":"NEOGENOMICS-INC-NEO-Quarterly-Deposits-Assets-Noncurrent","description":"SEC Name: DepositsAssetsNoncurrent","updated_at":"2014-03-06T20:00:42Z","frequency":"annual","from_date":"2010-12-31","to_date":"2011-09-30","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273220,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSOUTSTANDINGWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM2_A","name":"LIGAND PHARMACEUTICALS INC  (LGND): Annual Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Annual-Sharebased-Compensation-Arrangement-By-Sharebased-Payment-Award-Options-Outstanding-Weighted-Average-Remaining-Contractual-Term2","description":"SEC Name: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2","updated_at":"2014-03-06T20:00:59Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273212,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSEXERCISABLEINTRINSICVALUE1_A","name":"LIGAND PHARMACEUTICALS INC  (LGND): Annual Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Annual-Sharebased-Compensation-Arrangement-By-Sharebased-Payment-Award-Options-Exercisable-Intrinsic-Value1","description":"SEC Name: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1","updated_at":"2014-03-06T20:00:59Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273203,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONSHARESAUTHORIZEDUNDERSTOCKOPTIONPLANSEXERCISEPRICERANGEUPPERRANGELIMIT_A","name":"LIGAND PHARMACEUTICALS INC  (LGND): Annual Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Annual-Share-Based-Compensation-Shares-Authorized-Under-Stock-Option-Plans-Exercise-Price-Range-Upper-Range-Limit","description":"SEC Name: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit","updated_at":"2014-03-06T20:00:59Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273211,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSEXPECTEDTERM1_A","name":"LIGAND PHARMACEUTICALS INC  (LGND): Annual Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Annual-Sharebased-Compensation-Arrangement-By-Sharebased-Payment-Award-Fair-Value-Assumptions-Expected-Term1","description":"SEC Name: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1","updated_at":"2014-03-06T20:00:42Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276555,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"HMST_TIERONERISKBASEDCAPITALTORISKWEIGHTEDASSETS_A","name":"HomeStreet, Inc.  (HMST): Annual Tier One Risk Based Capital To Risk Weighted Assets","urlize_name":"HomeStreet-Inc-HMST-Annual-Tier-One-Risk-Based-Capital-To-Risk-Weighted-Assets","description":"SEC Name: TierOneRiskBasedCapitalToRiskWeightedAssets","updated_at":"2014-03-06T20:00:42Z","frequency":"annual","from_date":"2011-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276557,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"HMST_TIMEDEPOSITMATURITIESNEXTROLLINGTWELVEMONTHS_A","name":"HomeStreet, Inc.  (HMST): Annual Time Deposit Maturities Next Rolling Twelve Months","urlize_name":"HomeStreet-Inc-HMST-Annual-Time-Deposit-Maturities-Next-Rolling-Twelve-Months","description":"SEC Name: TimeDepositMaturitiesNextRollingTwelveMonths","updated_at":"2014-03-06T20:00:59Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10272037,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"NEO_EMPLOYEERELATEDLIABILITIESCURRENT_Q","name":"NEOGENOMICS INC  (NEO): Quarterly Employee Related Liabilities Current","urlize_name":"NEOGENOMICS-INC-NEO-Quarterly-Employee-Related-Liabilities-Current","description":"SEC Name: EmployeeRelatedLiabilitiesCurrent","updated_at":"2014-03-06T20:00:59Z","frequency":"annual","from_date":"2010-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276519,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"SMA_DERIVATIVELIABILITIESCURRENT_A","name":"Symmetry Medical Inc.  (SMA): Annual Derivative Liabilities Current","urlize_name":"Symmetry-Medical-Inc-SMA-Annual-Derivative-Liabilities-Current","description":"SEC Name: DerivativeLiabilitiesCurrent","updated_at":"2014-03-06T20:00:59Z","frequency":"annual","from_date":"2011-12-31","to_date":"2012-12-29","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276556,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"HMST_TIERONERISKBASEDCAPITALTORISKWEIGHTEDASSETS_Q","name":"HomeStreet, Inc.  (HMST): Quarterly Tier One Risk Based Capital To Risk Weighted Assets","urlize_name":"HomeStreet-Inc-HMST-Quarterly-Tier-One-Risk-Based-Capital-To-Risk-Weighted-Assets","description":"SEC Name: TierOneRiskBasedCapitalToRiskWeightedAssets","updated_at":"2014-03-06T20:00:42Z","frequency":"annual","from_date":"2011-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276357,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"NEO_EARNINGSPERSHAREBASICANDDILUTED_Q","name":"NEOGENOMICS INC  (NEO): Quarterly Earnings Per Share Basic And Diluted","urlize_name":"NEOGENOMICS-INC-NEO-Quarterly-Earnings-Per-Share-Basic-And-Diluted","description":"SEC Name: EarningsPerShareBasicAndDiluted","updated_at":"2014-03-06T20:00:42Z","frequency":"daily","from_date":"2011-06-30","to_date":"2011-09-30","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273225,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONSHARESAUTHORIZEDUNDERSTOCKOPTIONPLANSEXERCISEPRICERANGEEXERCISABLEOPTIONSWEIGHTEDAVERAGEEXERCISEPRICE1_Q","name":"LIGAND PHARMACEUTICALS INC  (LGND): Quarterly Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Quarterly-Sharebased-Compensation-Shares-Authorized-Under-Stock-Option-Plans-Exercise-Price-Range-Exercisable-Options-Weighted-Average-Exercise-Price1","description":"SEC Name: SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1","updated_at":"2014-03-06T20:01:00Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273208,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSEXERCISABLEWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM1_A","name":"LIGAND PHARMACEUTICALS INC  (LGND): Annual Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Annual-Sharebased-Compensation-Arrangement-By-Sharebased-Payment-Award-Options-Exercisable-Weighted-Average-Remaining-Contractual-Term1","description":"SEC Name: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1","updated_at":"2014-03-06T20:00:42Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10273223,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"LGND_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDANDEXPECTEDTOVESTOUTSTANDINGWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM1_A","name":"LIGAND PHARMACEUTICALS INC  (LGND): Annual Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1","urlize_name":"LIGAND-PHARMACEUTICALS-INC-LGND-Annual-Sharebased-Compensation-Arrangement-By-Sharebased-Payment-Award-Options-Vested-And-Expected-To-Vest-Outstanding-Weighted-Average-Remaining-Contractual-Term1","description":"SEC Name: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1","updated_at":"2014-03-06T20:00:42Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":10276562,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"HMST_TIMEDEPOSITMATURITIESROLLINGYEARFIVE_A","name":"HomeStreet, Inc.  (HMST): Annual Time Deposit Maturities Rolling Year Five","urlize_name":"HomeStreet-Inc-HMST-Annual-Time-Deposit-Maturities-Rolling-Year-Five","description":"SEC Name: TimeDepositMaturitiesRollingYearFive","updated_at":"2014-03-06T20:01:00Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null}],"sources":[{"id":651,"code":"SEC","datasets_count":4867,"description":"The Securities and Exchange commission is an agency of the United States government.\r\n\r\n\r\nTheir purpose is to regulate stock markets, and in doing so collect and distribute data on all publicly listed companies. ","name":"U.S. Securities and Exchange Commission","host":"www.sec.gov"}]}